Siddiqi, Mustaqeem A

P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 856-857

10.1097/01.hs9.0000846732.06415.be